公开(公告)号：US20230346917A1

公开(公告)日：2023-11-02

申请号：US17918304

申请日：2021-04-03

申请人： NOVOSCOPE IP LIMITED

发明人： Jasper CLUBE

IPC分类号： C12N7/00 ,  A61P31/14 ,  C12N15/86 ,  A61K9/00 ,  A61K39/215

CPC分类号： A61K39/215 ,  A61K9/0078 ,  A61P31/14 ,  C12N7/00 ,  C12N15/86 ,  A61K2039/5258 ,  C12N2770/20022 ,  C12N2770/20023 ,  C12N2770/20034 ,  C12N2770/20043 ,  C12N2770/20051 ,  C12N2770/20062

摘要： The invention provides competitive particles, such as virus-like particles, RNAs and DNAs for the treatment or prevention of viral infections and methods of using such particles for treating or preventing or reducing the risk of viral infections (or symptoms thereof) in a subject, such as a human or animal subject. For example, the method herein is a method of reducing or reducing the establishment of a zoonotic population of a virus in an animal, such as a livestock or wild animal (eg, a bat, camelid or a Pholidota (eg, a pangolin)).

公开(公告)号：US20190038730A1

公开(公告)日：2019-02-07

申请号：US16076479

申请日：2017-02-13

申请人： Novoscope IP Limited

发明人： Jasper CLUBE

IPC分类号： A61K39/00 ,  C07K14/725 ,  C07K14/705 ,  C07K16/28 ,  A61K39/395

摘要： The present invention relates to engineered cells, engineered chimaeric antigen ligands (CALs), novel uses of multi-specific binding agents for bridging cells, and methods of therapy. The invention also provides variation-matched engineered cells.

公开(公告)号：US20210177951A1

公开(公告)日：2021-06-17

申请号：US17179815

申请日：2021-02-19

申请人： Novoscope IP Limited

发明人： Jasper CLUBE

IPC分类号： A61K39/00 ,  C07K14/725 ,  C07K16/28 ,  A61K39/395 ,  C07K14/705

摘要： The present invention relates to engineered cells, engineered chimaeric antigen ligands (CALs), and novel uses of multi-specific binding agents for bridging cells. The invention also provides variation-matched engineered cells.